Israel Englander’s Alder Biopharmaceuticals ALDR Stock Holding History

Israel Englander’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-457,300	Closed	-$8.62M	–	4890
2019 Q3	$8.62M	Buy	+457,300	New	+$5.23M	0.01%	1383
2017 Q3	–	Sell	-250,000	Closed	-$2.86M	–	4069
2017 Q2	$2.86M	Buy	+250,000	New	+$4.62M	0.01%	1860

Israel Englander's ALDR Position: Q4 2019 in Review

Israel Englander sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 2,654,751 shares — an estimated $50.1M sold.

Israel Englander first reported a position in ALDR in Q3 2014 and held it in 17 quarters. The position peaked at $78M in Q2 2015. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

Israel Englander reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
Israel Englander sold 2,654,751 Alder Biopharmaceuticals shares in Q4 2019, an estimated $50.1M.
Israel Englander first reported a position in Alder Biopharmaceuticals in Q3 2014 and held it in 17 quarters.
Israel Englander's Alder Biopharmaceuticals position peaked at $78M in Q2 2015.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Millennium Management's 13F filing for Q4 2019, filed 14 Feb 2020.